Literature DB >> 15788348

Fever during post-acute rehabilitation in patients with brain injury.

Nilufer Kutay Ordu Gokkaya1, Meltem Dalyan Aras, Oznur Oken, Fusun Koseoglu.   

Abstract

OBJECTIVE: To investigate the incidence of fever during the post-acute rehabilitation phase in patients with brain injury.
DESIGN: Prospective study.
SUBJECTS: Seventy-four patients with brain injury.
METHODS: Patients were evaluated for the presence of fever during the rehabilitation phase. Demographics, time since injury, acute hospital and rehabilitation stay, brain injury and clinical characteristics were recorded for all subjects.
RESULTS: Of the study group, 36 patients (36/74; 48.6%) had at least 1 event qualified as fever. The most common cause of fever was urinary tract infection. There were only 2 patients considered as having central fever. Fever was significantly more frequent in patients with a greater number of neurological impairments, more severe neurological impairments and a lower level of independence. The rehabilitation stay was prolonged in patients with fever. The average length of rehabilitation stay was 62.5 days and 49.8 days in patients with or without fever, respectively.
CONCLUSION: Infection is the most common cause of fever after brain injury and the incidence of central fever is low.

Entities:  

Mesh:

Year:  2005        PMID: 15788348     DOI: 10.1080/16501970410001096

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  2 in total

1.  Factors Affecting Length of Stay in Adult Outpatient Physical Rehabilitation: A Scoping Review of the Literature.

Authors:  Arthur Woznowski-Vu; Christina Da Costa; Félix Turgeon-Provost; Kristin Dagenais; Bianca Roy-Mathie; Martina Aggban; Richard Preuss
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

2.  Effectively managing intractable central hyperthermia in a stroke patient by bromocriptine: a case report.

Authors:  Kuo-Wei Yu; Yu-Hui Huang; Chien-Lin Lin; Chang-Zern Hong; Li-Wei Chou
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-03       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.